William Stohl, MD, PhD

Title(s)Professor of Medicine
SchoolKeck School of Medicine of Usc
AddressHMR 711
Health Sciences Campus
Los Angeles CA 90089-9099
Phone+1 323 442 1959
vCardDownload vCard
    Other Positions
    Title(s)Chief, Division of Rheumatology

    Collapse Biography 
    Collapse Awards and Honors
    University of Pennsylvania School of Medicine1979Upjohn Award
    Arthritis Foundation Southern California Chapter2003James R. Klinenberg, M.D. Award

    Collapse Overview 
    Collapse Overview
    Dr. Stohl’s research focus is on systemic lupus erythematosus (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); rheumatoid arthritis (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); Sjogren's syndrome (biomarkers, novel therapeutics); and B cells (basic biology, role in autoimmune diseases, development of targeted therapies).

    Dr. Stohl received his M.D. (1977) and his Ph.D. (1979) from the University Pennsylvania.

    Collapse Research 
    Collapse Research Activities and Funding
    The vital role of BAFF in the development of SLE
    NIH R01AR050193May 16, 2006 - Aug 31, 2012
    Role: Principal Investigator
    NIH R01AR041006Aug 12, 1993 - Jun 30, 2002
    Role: Principal Investigator
    NIH R23AR036527Jan 1, 1986 - Jun 30, 1989
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Required Scholarly Project Mentor

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death Dis. 2024 Feb 14; 15(2):140. Shojaie L, Bogdanov JM, Alavifard H, Mohamed MG, Baktash A, Ali M, Mahov S, Murray S, Kanel GC, Liu ZX, Ito F, In GK, Merchant A, Stohl W, Dara L. PMID: 38355725; PMCID: PMC10866933.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Industry Payments to United States Rheumatologist-Authors of Publications in High-Impact Rheumatology Journals. ACR Open Rheumatol. 2023 Nov; 5(11):609-618. Stohl W, Parikh K. PMID: 37675758; PMCID: PMC10642244.
      View in: PubMed   Mentions:
    3. Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models. J Autoimmun. 2023 09; 139:103084. Jiwrajka N, Toothacre NE, Beethem ZT, Sting S, Forsyth KS, Dubin AH, Driscoll A, Stohl W, Anguera MC. PMID: 37399593.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    4. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms. Commun Biol. 2023 03 20; 6(1):295. Taghi Khani A, Kumar A, Sanchez Ortiz A, Radecki KC, Aramburo S, Lee SJ, Hu Z, Damirchi B, Lorenson MY, Wu X, Gu Z, Stohl W, Sanz I, Meffre E, Müschen M, Forman SJ, Koff JL, Walker AM, Swaminathan S. PMID: 36941341; PMCID: PMC10027679.
      View in: PubMed   Mentions: 1  Translation:HumansAnimals
    5. Belimumab for the treatment of pediatric patients with lupus nephritis. Expert Opin Biol Ther. 2023 03; 23(3):243-251. Stohl W, Kwok A. PMID: 36750049.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Maternal and cord blood BAFF and APRIL levels during pregnancy. Am J Reprod Immunol. 2023 03; 89(3):e13654. Stohl HE, Stohl W. PMID: 36398594.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. B Cell and T Cell Dissimilarities in BAFF-Deficient versus BR3-Deficient C57BL/6 Mice. J Immunol. 2022 12 01; 209(11):2133-2140. Stohl W, Yu N, Wu Y. PMID: 36426969.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    8. Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2022 Nov; 74(11):1822-1828. Urowitz MB, Aranow C, Asukai Y, Bass DL, Bruce IN, Chauhan D, Dall'Era M, Furie R, Fox NL, Gilbride JA, Hammer A, Ginzler EM, Gonzalez-Rivera T, Levy RA, Merrill JT, Quasny H, Roth DA, Stohl W, van Vollenhoven R, Wallace DJ, Petri M. PMID: 35439360.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Preferential Expansion of Foxp3+ T Regulatory Cells in CTLA-4-Deficient and CTLA-4-Haploinsufficient C57BL/6 Mice. Immunohorizons. 2022 07 25; 6(7):507-514. Stohl W, Yu N, Wu Y. PMID: 35878937.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    10. Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE. Lupus Sci Med. 2022 02; 9(1). Struemper H, Kurtinecz M, Edwards L, Freimuth WW, Roth DA, Stohl W. PMID: 35131846; PMCID: PMC8823257.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    11. First-trimester serum BAFF:sFlt-1 ratio as a candidate early biomarker of spontaneous abortion. Am J Reprod Immunol. 2021 10; 86(4):e13428. Stohl HE, Yu N, Stohl W. PMID: 33837577.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. Lupus. 2021 Apr; 30(5):795-806. Seridi L, Cesaroni M, Orillion A, Schreiter J, Chevrier M, Marciniak S, Migone TS, Stohl W, Chatham WW, Furie RA, Benson J, Jordan J. PMID: 33626969.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    13. Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. Ann Rheum Dis. 2021 06; 80(6):727-738. Westhovens R, Rigby WFC, van der Heijde D, Ching DWT, Stohl W, Kay J, Chopra A, Bartok B, Matzkies F, Yin Z, Guo Y, Tasset C, Sundy JS, Jahreis A, Mozaffarian N, Messina OD, Landewé RB, Atsumi T, Burmester GR. PMID: 33452004; PMCID: PMC8142453.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCTClinical Trials
    14. Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice. J Transl Autoimmun. 2021; 4:100075. Chu SY, Pong E, Bonzon C, Yu N, Jacob CO, Chalmers SA, Putterman C, Szymkowski DE, Stohl W. PMID: 33409482; PMCID: PMC7773957.
      View in: PubMed   Mentions: 4  
    15. Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial. Lancet Rheumatol. 2021 Feb; 3(2):e122-e130. Sheikh SZ, Scheinberg MA, Wei JC, Tegzova D, Stohl W, de Toledo RA, Mucenic T, Banfi MRA, Maksimowicz-McKinnon K, Abud-Mendoza C, Navarra S, Garcia M, Garcia-De La Torre I, Ros JO, Levy RA, Bass DL, Terrés JR, Punwaney R, Harris J, Nami A, Pierce A, Thorneloe KS, Ji B, Roth DA. PMID: 38279368.
      View in: PubMed   Mentions: 4  
    16. Systemic lupus erythematosus (SLE): emerging therapeutic targets. Expert Opin Ther Targets. 2020 12; 24(12):1283-1302. Mathias LM, Stohl W. PMID: 33034541.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    17. First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial. Lancet Rheumatol. 2020 Oct; 2(10):e613-e622. Jordan J, Benson J, Chatham WW, Furie RA, Stohl W, Wei JC, Marciniak S, Yao Z, Srivastava B, Schreiter J, Cesaroni M, Orillion A, Seridi L, Chevrier M. PMID: 38273624.
      View in: PubMed   Mentions: 1  
    18. Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents. Front Med (Lausanne). 2020; 7:303. Wise LM, Stohl W. PMID: 32695790; PMCID: PMC7338653.
      View in: PubMed   Mentions: 28  
    19. Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF. Arthritis Res Ther. 2020 05 07; 22(1):106. Song YJ, Choi IA, Meylan F, Demoruelle MK, Farley T, Richard AC, Hawley E, Botson J, Hong YJ, Lee EY, Mian SR, Hamilton BC, Thiele GM, Mikuls TR, Gara N, Ward CD, Lamberth S, Deane KD, Heller T, Ward MM, Lee DM, Migone TS, Stohl W, O'Dell JR, Norris JM, Holers VM, Gregersen P, Song YW, Siegel RM. PMID: 32381123; PMCID: PMC7204024.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    20. Promotion of T Regulatory Cells in Mice by B Cells and BAFF. J Immunol. 2020 05 01; 204(9):2416-2428. Stohl W, Yu N. PMID: 32213563.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    21. Development of Murine Systemic Lupus Erythematosus in the Absence of BAFF. Arthritis Rheumatol. 2020 02; 72(2):292-302. Stohl W, Yu N, Chalmers S, Putterman C, Jacob CO. PMID: 31493335; PMCID: PMC6994329.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    22. The safety of belimumab for the treatment of systemic lupus erythematosus. Expert Opin Drug Saf. 2019 Dec; 18(12):1133-1144. Wise LM, Stohl W. PMID: 31657965.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    23. Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 07; 71(7):1125-1134. Wallace DJ, Ginzler EM, Merrill JT, Furie RA, Stohl W, Chatham WW, Weinstein A, McKay JD, McCune WJ, Petri M, Fettiplace J, Roth DA, Ji B, Heath A. PMID: 30771238; PMCID: PMC6617785.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    24. IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation. J Invest Dermatol. 2019 12; 139(12):2477-2487. Wilson RP, McGettigan SE, Dang VD, Kumar A, Cancro MP, Nikbakht N, Stohl W, Debes GF. PMID: 31152755; PMCID: PMC6874734.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    25. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheum. 2019 12; 49(3):485-492. Stohl W, Kenol B, Kelly AJ, Ananth Correa A, Panush RS. PMID: 31153707.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. Constitutive reduction in the checkpoint inhibitor, CTLA-4, does not accelerate SLE in NZM 2328 mice. Lupus Sci Med. 2019; 6(1):e000313. Stohl W, Yu N, Chalmers SA, Putterman C, Jacob CO. PMID: 31168399; PMCID: PMC6519407.
      View in: PubMed   Mentions: 2     Fields:    
    27. Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study. Lupus Sci Med. 2018; 5(1):e000288. van Vollenhoven RF, Stohl W, Furie RA, Fox NL, Groark JG, Bass D, Kurtinecz M, Pobiner BF, Eastman WJ, Gonzalez-Rivera T, Gordon D. PMID: 30588323; PMCID: PMC6280901.
      View in: PubMed   Mentions: 3     Fields:    
    28. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep. 2018 07 23; 8(1):11044. Edman MC, Janga SR, Meng Z, Bechtold M, Chen AF, Kim C, Naman L, Sarma A, Teekappanavar N, Kim AY, Madrigal S, Singh S, Ortiz E, Christianakis S, Arkfeld DG, Mack WJ, Heur M, Stohl W, Hamm-Alvarez SF. PMID: 30038391; PMCID: PMC6056496.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    29. Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2018 08; 70(8):1256-1264. Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer AE, Groark J, Bass D, Fox NL, Roth D, Gordon D. PMID: 29671280; PMCID: PMC6099508.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    30. A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus. Lupus. 2018 Aug; 27(9):1489-1498. Doria A, Bass D, Schwarting A, Hammer A, Gordon D, Scheinberg M, Fox NL, Groark J, Stohl W, Kleoudis C, Roth D. PMID: 29807477; PMCID: PMC6066857.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    31. Maternal Serum B-Cell Activating Factor Levels: Candidate Early Biomarker for Hypertensive Disorders of Pregnancy. Hypertension. 2017 11; 70(5):1007-1013. Stohl HE, Lee RH, Manetta J, Kikly K, Korst LM, Stohl W. PMID: 28923901.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    32. Systemic lupus erythematosus: BAFF emerges from the genetic shadows. Nat Rev Rheumatol. 2017 08; 13(8):456-457. Stohl W. PMID: 28615729.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Rheumatol. 2017 05; 69(5):1016-1027. Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. PMID: 28118533; PMCID: PMC5434872.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    34. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest. 2017 May 01; 127(5):1651-1663. Sindhava VJ, Oropallo MA, Moody K, Naradikian M, Higdon LE, Zhou L, Myles A, Green N, Nündel K, Stohl W, Schmidt AM, Cao W, Dorta-Estremera S, Kambayashi T, Marshak-Rothstein A, Cancro MP. PMID: 28346226; PMCID: PMC5409796.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    35. Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE). Expert Rev Clin Immunol. 2017 06; 13(6):623-633. Stohl W. PMID: 28164726.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    36. Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clin Rheumatol. 2017 Mar; 36(3):507-516. Johnson J, Yeter K, Rajbhandary R, Neal R, Tian Q, Jian J, Fadle N, Thurner L, Liu C, Stohl W. PMID: 27830341.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. B cell-independent contribution of BAFF to murine autoimmune disease. Clin Immunol. 2016 Nov; 172:111-116. Stohl W, Banfalvi A. PMID: 27430521.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    38. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors. Arthritis Rheumatol. 2015 Sep; 67(9):2523-35. Jacob CO, Yu N, Sindhava V, Cancro MP, Pawar RD, Putterman C, Stohl W. PMID: 25989238.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    39. Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. Arthritis Res Ther. 2015 Aug 20; 17:215. Stohl W, Merrill JT, Looney RJ, Buyon J, Wallace DJ, Weisman MH, Ginzler EM, Cooke B, Holloway D, Kaliyaperumal A, Kuchimanchi KR, Cheah TC, Rasmussen E, Ferbas J, Belouski SS, Tsuji W, Zack DJ. PMID: 26290435; PMCID: PMC4545922.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    40. Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2016 Feb; 75(2):332-40. Merrill JT, van Vollenhoven RF, Buyon JP, Furie RA, Stohl W, Morgan-Cox M, Dickson C, Anderson PW, Lee C, Berclaz PY, Dörner T. PMID: 26293163.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCellsCTClinical Trials
    41. A dendritic-cell-stromal axis maintains immune responses in lymph nodes. Immunity. 2015 Apr 21; 42(4):719-30. Kumar V, Dasoveanu DC, Chyou S, Tzeng TC, Rozo C, Liang Y, Stohl W, Fu YX, Ruddle NH, Lu TT. PMID: 25902483; PMCID: PMC4591553.
      View in: PubMed   Mentions: 44     Fields:    Translation:AnimalsCells
    42. Editorial: the BAFFling immunology of systemic lupus erythematosus: beyond B cells. Arthritis Rheumatol. 2015 Mar; 67(3):612-5. Stohl W. PMID: 25385361.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    43. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome. Arthritis Rheumatol. 2014 Jul; 66(7):1872-81. Hamm-Alvarez SF, Janga SR, Edman MC, Madrigal S, Shah M, Frousiakis SE, Renduchintala K, Zhu J, Bricel S, Silka K, Bach D, Heur M, Christianakis S, Arkfeld DG, Irvine J, Mack WJ, Stohl W. PMID: 24644101; PMCID: PMC4077975.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimals
    44. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor. Arthritis Rheumatol. 2014 May; 66(5):1153-64. Chu SY, Yeter K, Kotha R, Pong E, Miranda Y, Phung S, Chen H, Lee SH, Leung I, Bonzon C, Desjarlais JR, Stohl W, Szymkowski DE. PMID: 24782179.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    45. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opin Ther Targets. 2014 Apr; 18(4):473-89. Stohl W. PMID: 24521424.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    46. APRIL mediates peritoneal B-1 cell homeostasis. Immunol Lett. 2014 Aug; 160(2):120-7. Sindhava VJ, Scholz JL, Stohl W, Cancro MP. PMID: 24512739; PMCID: PMC4058418.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    47. Lloyd Mayer, MD, 1952-2013, In Memoriam. Clin Immunol. 2014 Feb; 150(2):A1-A2. Fu SM, Cunningham-Rundles C, Diamond B, Rotrosen D, Stohl W, Terhorst C. PMID: 32942520.
      View in: PubMed   Mentions:    Fields:    
    48. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation. J Exp Med. 2014 Jan 13; 211(1):45-56. Goenka R, Matthews AH, Zhang B, O'Neill PJ, Scholz JL, Migone TS, Leonard WJ, Stohl W, Hershberg U, Cancro MP. PMID: 24367004; PMCID: PMC3892970.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    49. Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus. J Rheumatol. 2014 Feb; 41(2):300-9. Ginzler EM, Wallace DJ, Merrill JT, Furie RA, Stohl W, Chatham WW, Weinstein A, McKay JD, McCune WJ, Zhong ZJ, Freimuth WW, Petri MA, LBSL02/99 Study Group. PMID: 24187095.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    50. Future prospects in biologic therapy for systemic lupus erythematosus. Nat Rev Rheumatol. 2013 Dec; 9(12):705-20. Stohl W. PMID: 24018550.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    51. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J Immunol. 2013 Aug 01; 191(3):1154-63. Shah HB, Joshi SK, Rampuria P, Devera TS, Lang GA, Stohl W, Lang ML. PMID: 23797666; PMCID: PMC3720783.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCellsPHPublic Health
    52. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum. 2013 Apr; 65(4):1043-54. Jacob CO, Yu N, Guo S, Jacob N, Quinn WJ, Sindhava V, Cancro MP, Goilav B, Putterman C, Migone TS, Stohl W. PMID: 23334904; PMCID: PMC3618582.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    53. Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study. J Rheumatol. 2013 May; 40(5):579-89. Stohl W, Merrill JT, McKay JD, Lisse JR, Zhong ZJ, Freimuth WW, Genovese MC. PMID: 23547209.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    54. Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):299-303. Chu LH, Portugal C, Kawatkar AA, Stohl W, Nichol MB. PMID: 22807272.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    55. Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development? Curr Rheumatol Rep. 2012 Aug; 14(4):303-9. Stohl W. PMID: 22547203.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    56. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012 Sep; 71(9):1567-1572. Kong N, Lan Q, Su W, Chen M, Wang J, Yang Z, Park R, Dagliyan G, Conti PS, Brand D, Liu Z, Stohl W, Zou H, Zheng SG. PMID: 22764040; PMCID: PMC4038329.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    57. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 2012 Jul; 64(7):2328-37. Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW, BLISS-52 Study Group, BLISS-76 Study Group. PMID: 22275291; PMCID: PMC3350827.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    58. Incremental expenditure of biologic disease modifying antirheumatic treatment using instrumental variables in panel data. Health Econ. 2013 Jul; 22(7):807-23. Kawatkar AA, Hay JW, Stohl W, Nichol MB. PMID: 22718267.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. J Rheumatol. 2012 Aug; 39(8):1632-40. Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ, Tegzová D, McKay JD, Avila-Armengol HE, Utset TO, Zhong ZJ, Hough DR, Freimuth WW, Migone TS, BLISS-76 Study Group. PMID: 22707609.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    60. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum. 2012 May; 64(5):1610-9. Jacob CO, Guo S, Jacob N, Pawar RD, Putterman C, Quinn WJ, Cancro MP, Migone TS, Stohl W. PMID: 22127792; PMCID: PMC3292707.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    61. Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial. Ann Rheum Dis. 2012 Aug; 71(8):1289-96. Stohl W, Gomez-Reino J, Olech E, Dudler J, Fleischmann RM, Zerbini CA, Ashrafzadeh A, Grzeschik S, Bieraugel R, Green J, Francom S, Dummer W. PMID: 22307942; PMCID: PMC3396459.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    62. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol. 2012 Jan 09; 30(1):69-77. Stohl W, Hilbert DM. PMID: 22231104; PMCID: PMC3264947.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    63. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011 Dec; 63(12):3918-30. Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzová D, Sanchez-Guerrero J, Schwarting A, Merrill JT, Chatham WW, Stohl W, Ginzler EM, Hough DR, Zhong ZJ, Freimuth W, van Vollenhoven RF, BLISS-76 Study Group. PMID: 22127708; PMCID: PMC5007058.
      View in: PubMed   Mentions: 524     Fields:    Translation:HumansCTClinical Trials
    64. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Ann Rheum Dis. 2012 Mar; 71(3):351-7. Tak PP, Rigby W, Rubbert-Roth A, Peterfy C, van Vollenhoven RF, Stohl W, Healy E, Hessey E, Reynard M, Shaw T. PMID: 22012969; PMCID: PMC3277723.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    65. BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One. 2011; 6(8):e23629. Zhou X, Xia Z, Lan Q, Wang J, Su W, Han YP, Fan H, Liu Z, Stohl W, Zheng SG. PMID: 21897850; PMCID: PMC3163640.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    66. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011 Jul 06; 13(4):228. Jacob N, Stohl W. PMID: 21745419; PMCID: PMC3239336.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimals
    67. Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside. Curr Opin Rheumatol. 2011 May; 23(3):305-10. Stohl W, Scholz JL, Cancro MP. PMID: 21330926; PMCID: PMC3154025.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    68. B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol. 2011 Apr 15; 186(8):4984-93. Jacob N, Guo S, Mathian A, Koss MN, Gindea S, Putterman C, Jacob CO, Stohl W. PMID: 21383240; PMCID: PMC3074466.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    69. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol. 2011 Apr 01; 186(7):4223-33. Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, Szymkowski DE. PMID: 21357255.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    70. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis. 2011 Jan; 70(1):39-46. Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM, IMAGE Investigators. PMID: 20937671.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCTClinical Trials
    71. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity. Arthritis Rheum. 2010 Aug; 62(8):2432-42. Stohl W, Jacob N, Guo S, Morel L. PMID: 20506216; PMCID: PMC2921019.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    72. Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes). Arthritis Res Ther. 2010; 12(2):111. Stohl W. PMID: 20441604; PMCID: PMC2888214.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    73. Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort. Arthritis Rheum. 2010 Feb; 62(2):392-401. Mavragani CP, La DT, Stohl W, Crow MK. PMID: 20112385; PMCID: PMC2821991.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    74. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2010 Feb; 43(1):84-97. Jacob N, Stohl W. PMID: 20014977; PMCID: PMC2809122.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    75. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients. Arthritis Rheum. 2009 Nov; 60(11):3400-9. Hong SD, Reiff A, Yang HT, Migone TS, Ward CD, Marzan K, Shaham B, Phei WC, Garza J, Bernstein B, Stohl W. PMID: 19877053.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    76. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol. 2009 Nov 01; 183(9):6021-9. Agrawal H, Jacob N, Carreras E, Bajana S, Putterman C, Turner S, Neas B, Mathian A, Koss MN, Stohl W, Kovats S, Jacob CO. PMID: 19812195; PMCID: PMC2766036.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    77. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther. 2009; 11(5):R143. Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C. PMID: 19785730; PMCID: PMC2787265.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    78. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 2009 Sep 15; 61(9):1168-78. Wallace DJ, Stohl W, Furie RA, Lisse JR, McKay JD, Merrill JT, Petri MA, Ginzler EM, Chatham WW, McCune WJ, Fernandez V, Chevrier MR, Zhong ZJ, Freimuth WW. PMID: 19714604; PMCID: PMC2758229.
      View in: PubMed   Mentions: 195     Fields:    Translation:HumansCTClinical Trials
    79. Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum. 2009 Sep 15; 61(9):1143-51. Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, Chatham WW, Strand V, Weinstein A, Chevrier MR, Zhong ZJ, Freimuth WW. PMID: 19714615; PMCID: PMC2748175.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    80. Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol. 2009 Feb 15; 182(4):2532-41. Jacob N, Yang H, Pricop L, Liu Y, Gao X, Zheng SG, Wang J, Gao HX, Putterman C, Koss MN, Stohl W, Jacob CO. PMID: 19201910; PMCID: PMC2790862.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    81. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis. 2009 Nov; 68(11):1768-74. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, Stohl W. PMID: 19054829.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    82. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2008; 10(5):R109. Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, Cai W, Freimuth W, Belimumab Study Group. PMID: 18786258; PMCID: PMC2592791.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCellsCTClinical Trials
    83. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2008 Aug; 58(8):2453-9. Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W. PMID: 18668552.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    84. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol. 2008 Jul 01; 181(1):833-41. Stohl W, Jacob N, Quinn WJ, Cancro MP, Gao H, Putterman C, Gao X, Pricop L, Koss MN. PMID: 18566449; PMCID: PMC2587218.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    85. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders. Ann Rheum Dis. 2008 Aug; 67(8):1132-8. La DT, Collins CE, Yang HT, Migone TS, Stohl W. PMID: 17967830.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    86. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis. 2008 Jul; 67(7):1011-6. Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W. PMID: 17962238.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    87. New and promising treatments for rheumatoid arthritis. Am J Orthop (Belle Mead NJ). 2007 Jul; 36(7 Suppl):18-23. Looney RJ, Stohl W. PMID: 17694190.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    88. Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 2006 Dec; 6(4):351-8. Stohl W. PMID: 17214581.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    89. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochem Biophys Res Commun. 2006 Oct 20; 349(2):838-45. Schaller M, Stohl W, Benoit V, Tan SM, Johansen L, Ditzel HJ. PMID: 16949042.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol. 2006 Aug 15; 177(4):2671-80. Jacob CO, Pricop L, Putterman C, Koss MN, Liu Y, Kollaros M, Bixler SA, Ambrose CM, Scott ML, Stohl W. PMID: 16888029; PMCID: PMC2896675.
      View in: PubMed   Mentions: 54     Fields:    Translation:Animals
    91. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks? Clin Immunol. 2006 Oct; 121(1):1-12. Stohl W, Looney RJ. PMID: 16697258.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    92. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol. 2006 Mar 15; 176(6):3321-9. Zheng SG, Wang JH, Stohl W, Kim KS, Gray JD, Horwitz DA. PMID: 16517699.
      View in: PubMed   Mentions: 130     Fields:    Translation:AnimalsCells
    93. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum. 2006 Mar; 54(3):723-32. Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. PMID: 16508933.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    94. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Ther. 2006; 8(1):R6. Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W. PMID: 16356193; PMCID: PMC1526545.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    95. Humoral autoimmunity in mice overexpressing B cell surface CD19: vital role for MHC class II. Clin Immunol. 2005 Sep; 116(3):257-64. Stohl W, Xu D, Kim KS, Tedder TF, Sato S. PMID: 15963762.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    96. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum. 2005 Jul; 52(7):2080-91. Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B, Metzger TE, Bixler SA, Hong YS, Ambrose CM, Mackay F, Morel L, Putterman C, Kotzin BL, Kalled SL. PMID: 15986357.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    97. BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists. Curr Dir Autoimmun. 2005; 8:289-304. Stohl W. PMID: 15564726.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    98. Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol. 2004 Oct; 155(1-2):161-71. Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Gilmore W, Cheema GS, Stohl W, Burnett ME, Ko D, Kachuck NJ, Weiner LP. PMID: 15342208.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    99. Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis. 2005 May; 64(5):743-9. Schaller M, Stohl W, Tan SM, Benoit VM, Hilbert DM, Ditzel HJ. PMID: 15458959; PMCID: PMC1755497.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    100. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis. 2004 Sep; 63(9):1096-103. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM. PMID: 15308519; PMCID: PMC1755113.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    101. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice. Arthritis Rheum. 2004 Jul; 50(7):2227-39. Stohl W, Xu D, Metzger TE, Kim KS, Morel L, Kotzin BL. PMID: 15248222.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    102. Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders. Expert Opin Ther Targets. 2004 Jun; 8(3):177-89. Stohl W. PMID: 15161425.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    103. MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4). Int Immunol. 2004 Jul; 16(7):895-904. Stohl W, Xu D, Kim KS, David CS, Allison JP. PMID: 15136557.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    104. A therapeutic role for BLyS antagonists. Lupus. 2004; 13(5):317-22. Stohl W. PMID: 15230285.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    105. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003 Dec; 48(12):3475-86. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM. PMID: 14673998.
      View in: PubMed   Mentions: 163     Fields:    Translation:HumansCells
    106. In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigens. Clin Immunol. 2003 Sep; 108(3):182-9. Kim KS, Jacob N, Stohl W. PMID: 14499241.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    107. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003 Apr; 48(4):982-92. Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W. PMID: 12687540.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    108. SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. Arthritis Res Ther. 2003; 5(3):136-8. Stohl W. PMID: 12723979; PMCID: PMC165050.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    109. B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr Rheumatol Rep. 2002 Aug; 4(4):345-50. Stohl W. PMID: 12126587.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    110. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients. Clin Immunol. 2002 Aug; 104(2):115-22. Stohl W, Cheema GS, Briggs WS, Xu D, Sosnovtseva S, Roschke V, Ferrara DE, Labat K, Sattler FR, Pierangeli SS, Hilbert DM. PMID: 12165272.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    111. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001 Jun; 44(6):1313-9. Cheema GS, Roschke V, Hilbert DM, Stohl W. PMID: 11407690.
      View in: PubMed   Mentions: 230     Fields:    Translation:HumansAnimals
    112. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death. Cell Immunol. 2000 Jul 10; 203(1):1-11. Stohl W, Xu D, Starling GC, Casali P, Kiener PA. PMID: 10915556.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    113. Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells. Lupus. 1999; 8(4):293-9. Stohl W, Hamilton AS, Deapen DM, Mack TM, Horwitz DA. PMID: 10413208.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    114. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells. J Immunol. 1998 Oct 01; 161(7):3292-8. Stohl W, Lynch DH, Starling GC, Kiener PA. PMID: 9759844.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    115. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses. J Immunol. 1998 Jun 01; 160(11):5231-8. Stohl W, Elliott JE, Lynch DH, Kiener PA. PMID: 9605118.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    116. TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus. 1998; 7(8):565-8. Sumida T, Maeda T, Taniguchi M, Nishioka K, Stohl W. PMID: 9863902.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    117. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin. Arthritis Rheum. 1997 Jun; 40(6):1130-7. Stohl W, Elliott JE, Li L, Podack ER, Lynch DH, Jacob CO. PMID: 9182924.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    118. Impaired recovery and cytolytic function of CD56+ T and non-T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation. Studies in unselected patients and monozygotic disease-discordant twins. Arthritis Rheum. 1996 Nov; 39(11):1840-51. Stohl W, Elliott JE, Hamilton AS, Deapen DM, Mack TM, Horwitz DA. PMID: 8912506.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    119. Treatment of rheumatoid arthritis. N Engl J Med. 1996 Sep 12; 335(11):821-2; author reply 822-3. Stohl W, Arkfeld DG. PMID: 8778593.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens. Clin Immunol Immunopathol. 1996 May; 79(2):122-33. Stohl W, Elliot JE. PMID: 8620618.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    121. Differential human T cell-dependent B cell differentiation induced by staphylococcal superantigens (SAg). Regulatory role for SAg-dependent B cell cytolysis. J Immunol. 1995 Aug 15; 155(4):1838-50. Stohl W, Elliott JE. PMID: 7636237.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    122. Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus. Arthritis Rheum. 1995 Apr; 38(4):506-16. Stohl W. PMID: 7718004.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    123. Enhancing effects of interleukin 2-treated peripheral blood mononuclear cells on subsequent B cell differentiation. Cell Immunol. 1994 Sep; 157(2):381-92. Stohl W, Elliott JE, Wang H, Lin YG, Horwitz DA. PMID: 8069923.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    124. Polyclonal in vitro T cell proliferation and T cell-dependent B cell differentiation supported by activated autologous B cells. Clin Immunol Immunopathol. 1994 Jul; 72(1):44-52. Stohl W, Elliott JE, Linsley PS. PMID: 7517348.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    125. Human T cell-dependent B cell differentiation induced by staphylococcal superantigens. J Immunol. 1994 Jul 01; 153(1):117-27. Stohl W, Elliott JE, Linsley PS. PMID: 7515921.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    126. Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity. Clin Immunol Immunopathol. 1992 Oct; 65(1):30-8. Stohl W, Elliott JE. PMID: 1395122.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    127. Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus. Clin Immunol Immunopathol. 1992 May; 63(2):163-72. Stohl W. PMID: 1611718.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    128. Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol. 1991 Jan 01; 146(1):47-52. Spertini F, Stohl W, Ramesh N, Moody C, Geha RS. PMID: 1701800.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    129. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Cell Immunol. 1990 Oct 15; 130(2):257-70. Stohl W, Crow MK. PMID: 1976440.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    130. Differential CD3/T cell antigen receptor-mediated IL-2 production in jurkat T cells. Dissociation of IL-2 response from total inositol phosphate and calcium responses. J Immunol. 1990 Aug 15; 145(4):1078-87. Stohl W, Hofman FM, Gray JD. PMID: 2143206.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    131. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components. J Immunol. 1990 May 15; 144(10):3718-25. Stohl W, Tovar Z, Talal N. PMID: 2139672.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    132. A novel role for accessory cells in T cell-dependent B cell differentiation. Cell Immunol. 1990 May; 127(2):458-69. Shiba K, Stohl W, Gray JD, Horwitz DA. PMID: 2328534.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    133. A functionally unique anti-CD3 monoclonal antibody cross-reactive with basal keratinocytes. Cell Immunol. 1989 Jul; 121(2):247-60. Stohl W, Gottlieb AB, Reeves WH. PMID: 2472221.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    134. Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen. Cell Immunol. 1989 Jun; 121(1):99-112. Crow MK, Kushner B, Jover JA, Friedman SM, Mechanic SE, Stohl W. PMID: 2524281.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    135. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation. Cell Immunol. 1989 May; 120(2):351-65. Stohl W, Linker-Israeli M. PMID: 2566387.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    136. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells. J Immunol. 1989 Apr 01; 142(7):2343-51. Sherris D, Stohl W, Mayer L. PMID: 2538506.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    137. Feedback inhibition of B cell differentiation by monomeric immunoglobulin. Int Rev Immunol. 1989; 5(2):189-95. Mayer L, Stohl W, Cunningham-Rundles C. PMID: 8691052.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    138. In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency. Clin Immunol Immunopathol. 1988 Nov; 49(2):273-82. Stohl W, Cunningham-Rundles C, Mayer L. PMID: 3262471.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    139. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation. Cell Immunol. 1988 Oct 01; 116(1):73-85. Stohl W, Posnett DN, Chiorazzi N. PMID: 2458845.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    140. Correlation between systemic lupus erythematosus and T4 epitope phenotype. Arthritis Rheum. 1987 Dec; 30(12):1412-5. Stohl W, Singer JZ. PMID: 2449224.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    141. Inhibition of T cell-dependent human B cell proliferation and B cell differentiation by polyspecific monomeric IgG. Clin Exp Immunol. 1987 Dec; 70(3):649-57. Stohl W, Mayer L. PMID: 3501745; PMCID: PMC1542192.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    142. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J Immunol. 1987 Mar 15; 138(6):1667-73. Stohl W, Posnett DN, Chiorazzi N. PMID: 2950165.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    143. Modulation of the immune response by immunoglobulin for intravenous use. II. Inhibitory effects of sera from treated patients. Clin Immunol Immunopathol. 1986 Nov; 41(2):273-80. Stohl W, Cunningham-Rundles C, Thompson C, Mayer L. PMID: 2429797.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    144. Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol. 1986 Jun 15; 136(12):4407-13. Stohl W. PMID: 2940294.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    145. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol. 1985 Oct; 62(1):200-7. Stohl W. PMID: 3933869; PMCID: PMC1577410.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    146. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells. N Engl J Med. 1985 Jun 27; 312(26):1671-8. Stohl W, Crow MK, Kunkel HG. PMID: 2582253.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    147. Heterogeneity in expression of the T4 epitope in black individuals. Scand J Immunol. 1984 Sep; 20(3):273-8. Stohl W, Kunkel HG. PMID: 6208600.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    148. Deficient OKT4 epitope on helper T cells in a patient with SLE: confusion with AIDS. N Engl J Med. 1984 06 07; 310(23):1531. Stohl W. PMID: 6232461.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    149. Detection of the precursor and effector cells of experimental allergic encephalomyelitis in the thoracic duct of the rat. Cell Immunol. 1980 Sep 01; 54(2):471-7. Stohl W, Gonatas NK. PMID: 6968247.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    150. Saturday classes and rounds. N Engl J Med. 1979 May 17; 300(20):1165. Stohl W. PMID: 431645.
      View in: PubMed   Mentions:    Fields:    
    151. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin. J Immunol. 1979 Mar; 122(3):920-5. Stohl W, Kaplan MS, Gonatas NK. PMID: 87421.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsPHPublic Health
    152. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. J Immunol. 1978 Sep; 121(3):844-50. Stohl W, Gonatas NK. PMID: 308523.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    153. Religious objections to autopsy. N Engl J Med. 1977 Oct 27; 297(17):953. Stohl W. PMID: 904683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    154. Distribution of the thy-1 antigen in cellular and subcellular fractions of adult mouse brain. J Immunol. 1977 Aug; 119(2):422-7. Stohl W, Gonatas NK. PMID: 69659.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells